The histological findings of C3d and C5b-9 on renal tumor cells led to the hypothesis that the complement system could be involved in the immune response against ccRCC [107] expression level and cellular distribution of CD46, CD55, and CD59 on renal clear cell carcinoma cells. The gene discussed is CD46; the disease is clear cell renal carcinoma.